Bixiye
Ophthalmic Antihistamine - Commercial
Step Therapy
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2021 - 2030 ee natiijooyinka 3613
Bixiye
Non-Preferred Drug with Continuation of Therapy - Medicaid
Prior Authorization
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Lupus - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Compounded Medications - Commercial
Formulary Exception, Coverage Exception
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2025
Bixiye
Anti-Influenza Agents - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2025
Bixiye
QP75-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Weight Loss Agents
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP73-21 Medical Drug Update – RSV Health Alert and Palivizumab (Synagis)
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP74-21 Chantix Recall and Shortage
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP72-21 Commercial and MHCP Pharmacy Benefit Exclusion for Saphnelo
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021